EV/EBITDA:
-9.81+0.19(+1.90%)Summary
- As of today (June 28, 2025), TVTX EV/EBITDA is -9.81, with a rise of +0.19 (+1.90%) during the most recent trading session on June 27, 2025.
- Over the past year, TVTX EV/EBITDA has dropped by -7.07 (-258.03%).
- TVTX EV/EBITDA is now -105.41% below its all-time high of 181.49.
Performance
TVTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TVTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.9% | -1.9% | -2.4% |
| 1 m1 month | +3.0% | -3.0% | -3.7% |
| 3 m3 months | -21.3% | -23.3% | -27.5% |
| 6 m6 months | -41.1% | -10.7% | -14.5% |
| ytdytd | -39.7% | -11.6% | -15.2% |
| 1 y1 year | -258.0% | +66.3% | +78.4% |
| 5 y5 years | +27.1% | +45.9% | -24.5% |
TVTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.45 | -3.8% | -10.21 | +3.9% |
| 3 m | 3-month | -7.86 | -24.8% | -13.38 | +26.7% |
| 6 m | 6-month | -6.95 | -41.1% | -13.38 | +26.7% |
| 1 y | 1-year | -2.74 | -258.0% | -13.38 | +26.7% |
| 3 y | 3-year | -2.05 | -378.5% | -13.38 | +26.7% |
| 5 y | 5-year | -2.05 | -378.5% | -26.18 | +62.5% |
| alltime | all time | 181.49 | -105.4% | -5339 | +99.8% |
TVTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -9.81(+39.7%) |
| 2024 | -7.02(+123.6%) |
| 2023 | -3.14(-60.4%) |
| 2022 | -7.93(-48.2%) |
| 2021 | -15.32(+40.4%) |
| 2020 | -10.91(+55.0%) |
| 2019 | -7.04(-50.8%) |
| Date | Value |
|---|---|
| 2018 | -14.31(-29.9%) |
| 2017 | -20.40(+3.9%) |
| 2016 | -19.64(-450.7%) |
| 2015 | 5.60(-130.3%) |
| 2014 | -18.48(+141.3%) |
| 2013 | -7.66(-99.7%) |
| 2012 | -2308.72 |
FAQ
- What is Travere Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Travere Therapeutics?
- What is TVTX EV/EBITDA year-to-date change?
- What is Travere Therapeutics EV/EBITDA year-on-year change?
What is Travere Therapeutics EV/EBITDA?
The current EV/EBITDA of TVTX is -9.81
What is the all time high EV/EBITDA for Travere Therapeutics?
Travere Therapeutics all-time high EV/EBITDA is 181.49
What is TVTX EV/EBITDA year-to-date change?
Travere Therapeutics EV/EBITDA has changed by -2.79 (-39.74%) since the beginning of the year
What is Travere Therapeutics EV/EBITDA year-on-year change?
Over the past year, TVTX EV/EBITDA has changed by -7.07 (-258.03%)